您的位置: 首页 > 2022年9月 第52卷 第5期 > 文字全文
2023年7月 第38卷 第7期11
目录

基于铁死亡相关的lncRNA在肺鳞癌预后的分析

Prognostic analysis based on ferroptosis related lncRNAs in lung squamous cell carcinoma

来源期刊: 广州医药 | 113-120 发布时间:2022-10-11 收稿时间:2025/11/13 18:18:30 阅读量:19
作者:
关键词:
肺鳞癌长链非编码核糖核酸铁死亡相关
lung squamous cell carcinomalncRNAferroptosis related
DOI:
10.3969/j.issn.1000-8535.2022.05.024
收稿时间:
2021-07-13 
修订日期:
 
接收日期:
 
引用总数:
2  
目的 探究铁死亡相关的lncRNA在肺鳞状上皮细胞癌(简称肺鳞癌)患者中的预后意义。方法 从美国癌症和肿瘤基因图谱数据库(the Cancer Genome Atlas,TCGA)中下载肺鳞癌数据551例,包括49例正常对照样本和502例肺鳞癌患者样本。筛选出与铁死亡相关基因的共表达的lncRNA,使用单变量Cox回归进一步筛选lncRNA,然后,使用Lasso回归和多元Cox回归分构建铁死亡相关的lncRNA模型。建立基于模型的风险评分,并使用Cox回归测试其是否为独立的预后因素。铁死亡相关lncRNAs的功能富集使用基因本体(Gene Ontology)和京都基因和基因组百科全书(Kyoto Encyclopedia of Genes and Genomes)可视化。结果 4个预后铁死亡相关的lncRNA(AC253536.6,FLJ46906LUCAT,AC022150.2)显著不同,这构建了铁死亡相关的lncRNA模型。此模型将肺鳞癌患者分为低风险组和高风险组。基于模型的风险评分是肺鳞癌患者的显著独立因素(HR =2.116,95%CI=1.513~2.961;P<0.001)。此外,4个lncRNA在铁死亡过程,代谢和肿瘤经典途径中均显著富集。结论 4个铁死亡相关的lncRNAs可能是肺鳞癌患者的分子生物标志物和治疗靶标。
Objective To explore the prognostic significance of ferroptosis related lncRNAs in patients with lung squamous cell carcinoma. Methods Data of 551 lung squamous cell carcinoma cases was downloaded from the Cancer Genome Atlas (TCGA) of the United States, including 49 normal control samples and 502 lung squamous cell carcinoma samples. The lncRNAs co-expressed with genes related to ferroptosis was screened out. Univariate Cox regression was used to further screen out the lncRNAs. Then, Lasso regression and multiple Cox regression were used to construct lncRNA models related to ferroptosis. A model-based risk score system was established and Cox regression was used to test whether it was an independent prognostic factor. The functional enrichment of ferroptosis related lncRNAs were visualized using Gene Ontology and Kyoto Encyclopedia of Genes and Genomes. Results The four prognostic ferroptosis related lncRNAs (AC253536.6, FLJ46906 LUCAT, AC022150.2) were significantly different, and the ferroptosis lncRNAs model was constrncted with them. This model divided lung squamous cell carcinoma patients into low-risk group and high-risk group. The model-based risk score was a significant independent factor for patients with lung squamous cell carcinoma (HR=2.116, 95% CI=1.513-2.961; P<0.001). In addition, the four lncRNAs were significantly enriched in metabolism and tumor classical pathways during the ferroptosis process. Conclusions The four ferroptosis lncRNAs could be molecular biomarkers and therapeutic targets for patients with lung squamous cell carcinoma.
1、 JIN K T, LU Z B, LV J Q, et al. The role of long non-coding RNAs in mediating chemoresistance by modulating autophagy in cancer[J]. RNA Biol,2020, 17(12):1727-1740. JIN K T, LU Z B, LV J Q, et al. The role of long non-coding RNAs in mediating chemoresistance by modulating autophagy in cancer[J]. RNA Biol,2020, 17(12):1727-1740.
2、 MATSUSHITA M, FREIGANG S, SCHNEIDER C, et al. T cell lipid peroxidation induces ferroptosis and prevents immunity to infection[J]. J Exp Med,2015, 212(4):555-568. MATSUSHITA M, FREIGANG S, SCHNEIDER C, et al. T cell lipid peroxidation induces ferroptosis and prevents immunity to infection[J]. J Exp Med,2015, 212(4):555-568.
3、 YAGODA N, von RECHENBERG M, ZAGANJOR E, et al. RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels[J]. Nature,2007, 447(7146):864-868. YAGODA N, von RECHENBERG M, ZAGANJOR E, et al. RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels[J]. Nature,2007, 447(7146):864-868.
4、 DIXON S J, LEMBERG K M, LAMPRECHT M R, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death[J]. Cell,2012, 149(5):1060-1072. DIXON S J, LEMBERG K M, LAMPRECHT M R, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death[J]. Cell,2012, 149(5):1060-1072.
5、 DOLL S, FREITAS F P, SHAH R, et al. FSP1 is a glutathione-independent ferroptosis suppressor[J]. Nature,2019, 575(7784):693-698. DOLL S, FREITAS F P, SHAH R, et al. FSP1 is a glutathione-independent ferroptosis suppressor[J]. Nature,2019, 575(7784):693-698.
6、 BERSUKER K, HENDRICKS J M, LI Z, et al. The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis[J]. Nature,2019, 575(7784):688-692. BERSUKER K, HENDRICKS J M, LI Z, et al. The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis[J]. Nature,2019, 575(7784):688-692.
7、 STOCKWELL B R, FRIEDMANN ANGELI J P, BAYIR H, et al. Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease[J]. Cell,2017, 171(2):273-285. STOCKWELL B R, FRIEDMANN ANGELI J P, BAYIR H, et al. Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease[J]. Cell,2017, 171(2):273-285.
8、 WANG M, MAO C, OUYANG L, et al. Correction to: Long noncoding RNA LINC00336 inhibits ferroptosis in lung cancer by functioning as a competing endogenous RNA[J]. Cell Death Differ,2020, 27(4):1447. WANG M, MAO C, OUYANG L, et al. Correction to: Long noncoding RNA LINC00336 inhibits ferroptosis in lung cancer by functioning as a competing endogenous RNA[J]. Cell Death Differ,2020, 27(4):1447.
9、 YANG Y, TAI W, LU N, et al. lncRNA ZFAS1 promotes lung fibroblast-to-myofibroblast transition and ferroptosis via functioning as a ceRNA through miR-150-5p/SLC38A1 axis[J]. Aging (Albany NY),2020, 12(10):9085-9102. YANG Y, TAI W, LU N, et al. lncRNA ZFAS1 promotes lung fibroblast-to-myofibroblast transition and ferroptosis via functioning as a ceRNA through miR-150-5p/SLC38A1 axis[J]. Aging (Albany NY),2020, 12(10):9085-9102.
10、 MAO C, WANG X, LIU Y, et al. A G3BP1-interacting lncRNA promotes ferroptosis and apoptosis in cancer via nuclear sequestration of p53[J]. Cancer Res,2018, 78(13):3484-3496. MAO C, WANG X, LIU Y, et al. A G3BP1-interacting lncRNA promotes ferroptosis and apoptosis in cancer via nuclear sequestration of p53[J]. Cancer Res,2018, 78(13):3484-3496.
11、 WANG M, MAO C, OUYANG L, et al. Long noncoding RNA LINC00336 inhibits ferroptosis in lung cancer by functioning as a competing endogenous RNA[J]. Cell Death Differ,2019, 26(11):2329-2343. WANG M, MAO C, OUYANG L, et al. Long noncoding RNA LINC00336 inhibits ferroptosis in lung cancer by functioning as a competing endogenous RNA[J]. Cell Death Differ,2019, 26(11):2329-2343.
12、 MATHEW R, KARANTZA-WADSWORTH V, WHITE E. Role of autophagy in cancer[J]. Nat Rev Cancer,2007, 7(12):961-967. MATHEW R, KARANTZA-WADSWORTH V, WHITE E. Role of autophagy in cancer[J]. Nat Rev Cancer,2007, 7(12):961-967.
13、 LIANG C, ZHANG X, YANG M, et al. Recent progress in ferroptosis inducers for cancer therapy[J]. Adv Mater,2019, 31(51):e1904197. LIANG C, ZHANG X, YANG M, et al. Recent progress in ferroptosis inducers for cancer therapy[J]. Adv Mater,2019, 31(51):e1904197.
14、 HASSANNIA B, VANDENABEELE P, VANDEN BERGHE T. Targeting ferroptosis to iron out cancer[J]. Cancer Cell,2019, 35(6):830-849. HASSANNIA B, VANDENABEELE P, VANDEN BERGHE T. Targeting ferroptosis to iron out cancer[J]. Cancer Cell,2019, 35(6):830-849.
15、 STOCKWELL B R, FRIEDMANN ANGELI J P, BAYIR H, et al. Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease[J]. Cell,2017, 171(2):273-285. STOCKWELL B R, FRIEDMANN ANGELI J P, BAYIR H, et al. Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease[J]. Cell,2017, 171(2):273-285.
16、 DIXON S J, LEMBERG K M, LAMPRECHT M R, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death[J]. Cell,2012, 149(5):1060-1072. DIXON S J, LEMBERG K M, LAMPRECHT M R, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death[J]. Cell,2012, 149(5):1060-1072.
17、 GUO F, HIROSHIMA K, WU D, et al. Prohibitin in squamous cell carcinoma of the lung: its expression and possible clinical significance[J]. Hum Pathol,2012, 43(8):1282-1288. GUO F, HIROSHIMA K, WU D, et al. Prohibitin in squamous cell carcinoma of the lung: its expression and possible clinical significance[J]. Hum Pathol,2012, 43(8):1282-1288.
18、 MATSUOKA Y, TAKAGI Y, NOSAKA K, et al. Cytoplasmic expression of maspin predicts unfavourable prognosis in patients with squamous cell carcinoma of the lung[J]. Histopathology,2016, 69(1):114-120. MATSUOKA Y, TAKAGI Y, NOSAKA K, et al. Cytoplasmic expression of maspin predicts unfavourable prognosis in patients with squamous cell carcinoma of the lung[J]. Histopathology,2016, 69(1):114-120.
19、 WANG Q, LIU S, ZHAO X, et al. MiR-372-3p promotes cell growth and metastasis by targeting FGF9 in lung squamous cell carcinoma[J]. Cancer Med,2017, 6(6):1323-1330. WANG Q, LIU S, ZHAO X, et al. MiR-372-3p promotes cell growth and metastasis by targeting FGF9 in lung squamous cell carcinoma[J]. Cancer Med,2017, 6(6):1323-1330.
20、 MAO Y, YANG D, HE J, et al. Epidemiology of lung cancer[J]. Surg Oncol Clin N Am,2016, 25(3):439-445. MAO Y, YANG D, HE J, et al. Epidemiology of lung cancer[J]. Surg Oncol Clin N Am,2016, 25(3):439-445.
21、 QIAN L, LIN L, DU Y, et al. MicroRNA-588 suppresses tumor cell migration and invasion by targeting GRN in lung squamous cell carcinoma[J]. Mol Med Rep,2016, 14(4):3021-3028. QIAN L, LIN L, DU Y, et al. MicroRNA-588 suppresses tumor cell migration and invasion by targeting GRN in lung squamous cell carcinoma[J]. Mol Med Rep,2016, 14(4):3021-3028.
22、 YU K H, ZHANG C, BERRY G J, et al. Predicting non-small cell lung cancer prognosis by fully automated microscopic pathology image features[J]. Nat Commun,2016(7):12474. YU K H, ZHANG C, BERRY G J, et al. Predicting non-small cell lung cancer prognosis by fully automated microscopic pathology image features[J]. Nat Commun,2016(7):12474.
23、 PIPERDI B, MERLA A, PEREZ-SOLER R. Targeting angiogenesis in squamous non-small cell lung cancer[J]. Drugs,2014, 74(4):403-413. PIPERDI B, MERLA A, PEREZ-SOLER R. Targeting angiogenesis in squamous non-small cell lung cancer[J]. Drugs,2014, 74(4):403-413.
24、 OBERNDORFER F, LLAUER L. Molecular pathology of lung cancer: current status and perspectives[J]. Curr Opin Oncol,2018, 30(2):69-76. OBERNDORFER F, LLAUER L. Molecular pathology of lung cancer: current status and perspectives[J]. Curr Opin Oncol,2018, 30(2):69-76.
25、 ZHANG Y, YANG Q, WANG S. MicroRNAs: a new key in lung cancer[J]. Cancer Chemother Pharmacol,2014, 74(6):1105-1111. ZHANG Y, YANG Q, WANG S. MicroRNAs: a new key in lung cancer[J]. Cancer Chemother Pharmacol,2014, 74(6):1105-1111.
26、 CHEUNG C H Y, JUAN H F. Quantitative proteomics in lung cancer[J]. J Biomed Sci,2017, 24(1):37. CHEUNG C H Y, JUAN H F. Quantitative proteomics in lung cancer[J]. J Biomed Sci,2017, 24(1):37.
27、 CHEN W J, TANG R X, HE R Q, et al. Clinical roles of the aberrantly expressed lncRNAs in lung squamous cell carcinoma: a study based on RNA-sequencing and microarray data mining[J].Oncotarget,2017,8(37):61282-61304. CHEN W J, TANG R X, HE R Q, et al. Clinical roles of the aberrantly expressed lncRNAs in lung squamous cell carcinoma: a study based on RNA-sequencing and microarray data mining[J].Oncotarget,2017,8(37):61282-61304.
28、 GAO L, GUO Y N, ZENG J H, et al. The expression, significance and function of cancer susceptibility candidate 9 in lung squamous cell carcinoma: A bioinformatics and in vitro investigation[J]. Int J Oncol,2019, 54(5):1651-1664. GAO L, GUO Y N, ZENG J H, et al. The expression, significance and function of cancer susceptibility candidate 9 in lung squamous cell carcinoma: A bioinformatics and in vitro investigation[J]. Int J Oncol,2019, 54(5):1651-1664.
29、 XU J, SHU Y, XU T, et al. Microarray expression profiling and bioinformatics analysis of circular RNA expression in lung squamous cell carcinoma[J]. Am J Transl Res,2018, 10(3):771-783. XU J, SHU Y, XU T, et al. Microarray expression profiling and bioinformatics analysis of circular RNA expression in lung squamous cell carcinoma[J]. Am J Transl Res,2018, 10(3):771-783.
1、刘秀丽.硫氢化钠对硫酸铍诱导人支气管上皮细胞铁自噬和铁死亡的拮抗作用[D].南华大学,2023.DOI:10.27234/d.cnki.gnhuu.2023.000298. 刘秀丽.硫氢化钠对硫酸铍诱导人支气管上皮细胞铁自噬和铁死亡的拮抗作用[D].南华大学,2023.DOI:10.27234/d.cnki.gnhuu.2023.000298.
2、于潇杰,程立浩,张浩,等.铁死亡与乳腺癌患者化疗耐药的关系研究进展[J].国际医药卫生导报,2024,30(03):353-356. 于潇杰,程立浩,张浩,等.铁死亡与乳腺癌患者化疗耐药的关系研究进展[J].国际医药卫生导报,2024,30(03):353-356.
上一篇
下一篇
出版者信息








《广州医药》公众号
目录